Jan J. Cornelissen

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

Medicine, Hematology, Oncology +13

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij et al. · Nature Communications · 2021 · 843 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

Tom Cupedo, Natasha K. Crellin, Natalie Papazian et al. · Nature Immunology · 2008 · 650 citations

Life Sciences, Developmental Biology, Immunology +14

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Richard E. Champlin, Norbert Schmitz, Mary M. Horowitz et al. · PubMed · 2000 · 508 citations

Medicine, Cell Biology, Hematology +14